- Investing Ideas
- Swiss Top Stock Picks from Analysts
Swiss Top Stock Picks from Analysts
Results
17
Companies which are more than 50% undervalued based on analyst price target.
17 companies
ALSO Holding
Market Cap: CHF 1.9b
Operates as a technology services provider for the ICT industry in Switzerland, Germany, the Netherlands, United Kingdom, Poland, and internationally.
ALSN
CHF 148.60
7D
5.2%
1Y
-33.8%
Interroll Holding
Market Cap: CHF 1.3b
Provides material-handling solutions in Europe, the Middle East, Africa, the Americas, and the Asia Pacific.
INRN
CHF 1,598.00
7D
6.7%
1Y
-7.8%
naturenergie holding
Market Cap: CHF 1.1b
Through its subsidiaries, engages in the production, distribution, and sale of electricity under the Naturenergie brand in Switzerland and internationally.
NEAG
CHF 33.00
7D
0.9%
1Y
2.2%
Basilea Pharmaceutica
Market Cap: CHF 669.9m
A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.
BSLN
CHF 54.50
7D
-1.1%
1Y
38.1%
medmix
Market Cap: CHF 353.4m
Designs, produces, and sells high-precision devices and services in Switzerland and internationally.
MEDX
CHF 8.69
7D
0.5%
1Y
-8.5%
CPH Group
Market Cap: CHF 340.5m
Develops, manufactures, and distributes chemical products and packaging solutions for pharmaceutical customers in Europe, Asia, and North and South America.
CPHN
CHF 56.80
7D
2.9%
1Y
-7.8%
Newron Pharmaceuticals
Market Cap: CHF 312.9m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 15.04
7D
-1.1%
1Y
149.4%
Mikron Holding
Market Cap: CHF 283.7m
Develops, produces, and markets automation solutions, machining systems, and cutting tools in the Switzerland, Europe, North America, the Asia Pacific, and internationally.
MIKN
CHF 17.00
7D
7.3%
1Y
12.3%
Peach Property Group
Market Cap: CHF 258.0m
Engages in investment and development of residential real estate properties in Germany and Switzerland.
PEAN
CHF 4.65
7D
-4.2%
1Y
-22.5%
Santhera Pharmaceuticals Holding
Market Cap: CHF 231.7m
A specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.
SANN
CHF 16.64
7D
3.4%
1Y
29.8%
BioVersys
Market Cap: CHF 155.0m
Researches and develops antimicrobial drugs for bacterial infections.
BIOV
CHF 26.50
7D
-10.5%
1Y
-24.3%
Varia US Properties
Market Cap: CHF 144.8m
A real estate investment company, acquires, holds, and sells properties in the United States.
VARN
CHF 14.30
7D
-12.8%
1Y
-31.6%
lastminute.com
Market Cap: CHF 131.1m
Operates in the online travel industry providing dynamic holiday packages in Italy, Spain, the United Kingdom, France, Germany, and internationally.
LMN
CHF 12.30
7D
3.4%
1Y
0%
Molecular Partners
Market Cap: CHF 126.5m
A clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland.
MOLN
CHF 3.38
7D
4.8%
1Y
4.5%
Curatis Holding
Market Cap: CHF 118.5m
Engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases.
CURN
CHF 23.00
7D
2.2%
1Y
134.7%
MindMaze Therapeutics Holding
Market Cap: CHF 45.5m
Develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology.
MMTX
CHF 0.30
7D
-6.3%
1Y
n/a
Asmallworld
Market Cap: CHF 9.0m
Operates a digital travel and lifestyle ecosystem worldwide.
ASWN
CHF 0.63
7D
1.6%
1Y
-50.0%